Neodent Implant System - Zirconia Implant System

K202282 · Jjgc Industria E Comercio DE Materiais Dentarios S.A. · NHA · Jan 29, 2021 · Dental

Device Facts

Record IDK202282
Device NameNeodent Implant System - Zirconia Implant System
ApplicantJjgc Industria E Comercio DE Materiais Dentarios S.A.
Product CodeNHA · Dental
Decision DateJan 29, 2021
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3630
Device ClassClass 2

Intended Use

Neodent prosthetic abutments are indicated to be used on Neodent implants to provide support for prosthetic structures for up to 6 months. They can be used in single- or two-stage procedures and they are intended to be placed out of occlusion.

Device Story

Temporary dental abutment; PEEK body with titanium alloy fixation screw; interfaces with Neodent zirconia implant bodies via ZiLock internal connection. Used by dental professionals in clinical settings to support provisional prosthetic structures. Device placed out of occlusion; intended for single use; provided sterile. Facilitates temporary rehabilitation; supports prosthetic structures during healing phase; removed after 6 months.

Clinical Evidence

Bench testing only. Biocompatibility, sterilization residuals, and bacterial endotoxin testing were leveraged from predicate K163194. MRI compatibility was leveraged from reference device K182620. Dynamic fatigue testing was deemed not applicable as the device is intended for use out of occlusion.

Technological Characteristics

Materials: PEEK (body), Titanium alloy ASTM F136 (screw). Connection: ZiLock internal indexing. Dimensions: 1.5-2.5mm length, 4.0-4.5mm diameter. Sterilization: Ethylene Oxide (SAL 10^-6). Connectivity: None (mechanical).

Indications for Use

Indicated for patients requiring temporary prosthetic support on Neodent implants for up to 6 months; suitable for single- or two-stage procedures; must be placed out of occlusion.

Regulatory Classification

Identification

An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. Underneath the square are the words "U.S. FOOD & DRUG ADMINISTRATION" in blue. JJGC Industria e Comercio de Materiais Dentarios SA % Jennifer Jackson Director of Regulatory Affairs Straumann USA, LLC 60 Minuteman Road Andover, Massachusetts 01810 Re: K202282 Trade/Device Name: Neodent Implant System - Zirconia Implant System Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: December 30, 2020 Received: December 31, 2020 Dear Jennifer Jackson: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or post-marketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely. Andrew Steen Assistant Director DHT1B: Division of Dental Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K202282 Device Name Neodent Implant System - Zirconia Implant System Indications for Use (Describe) Indications for Use for PEEK Abutment for Zirconia Implant System: Neodent prosthetic abutments are indicated to be used on Neodent implants to provide support for prosthetic structures for up to 6 months. They can be used in single- or two-stage procedures and they are intended to be placed out of occlusion. | Type of Use (Select one or both, as applicable) | |-------------------------------------------------| |-------------------------------------------------| | <div><span style="font-size:16px;"> </span> <span style="font-size:16px;"><b> </b></span></div> Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) | |----------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------| |----------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------| CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ ### 510(k) Summary ### ADMINISTRATIVE INFORMATION | Sponsor | JJGC Indústria e Comércio de Materiais Dentários SA | |---------------------------------|-----------------------------------------------------| | | (dba Neodent) | | | Av. Juscelino Kubitschek de Oliveira, 3291 | | | Curitiba, Parana, Brazil 81270-200 | | | Registration No.: 3008261720 | | | Owner/Operator No.: 10031702 | | Contact Person | Jennifer M. Jackson, MS | | | Director of Regulatory Affairs, | | | Straumann USA | | | E-mail: jennifer.jackson@straumann.com | | | Telephone (978) 747-2509 | | Date Prepared | 26/Jan/2021 | | Preparer / Alternate<br>Contact | Mariana Soares Hartmann | | | Regulatory Affairs Analyst | | | JJGC Indústria e Comércio de Materiais Dentários SA | | | E-mail: mariana.hartmann@neodent.com | ## DEVICE NAME AND CLASSIFICATION | Trade/ Proprietary Name | Neodent Implant System – Zirconia Implant System | |----------------------------|--------------------------------------------------| | Common Name | Endosseous dental implant abutment | | Classification Name | Endosseous dental implant abutment | | Classification Regulations | 21 CFR 872.3630, Class II | | Product Code | NHA | | Classification Panel | Dental Products Panel | | Reviewing Branch | Dental Devices Branch | {4}------------------------------------------------ ### PREDICATE DEVICE INFORMATION | Primary Predicate Device | K163194 – Neodent Implant System – GM Line, JJGC Indústria e<br>Comércio de Materiais Dentários S.A | |--------------------------|--------------------------------------------------------------------------------------------------------------------------| | Reference Device | K201491 – Neodent Implant System – Zirconia Implant System,<br>JJGC Indústria e Comércio de Materiais Dentários S.A | | Reference Device | K191191 – Neodent Implant System, JJGC Indústria e Comércio<br>de Materiais Dentários S.A | | Reference Device | K182620 - MRI Compatibility for Existing Neodent Implant<br>System, JJGC Indústria e Comércio de Materiais Dentários S.A | ### INDICATIONS FOR USE Neodent prosthetic abutments are indicated to be used on Neodent implants to provide support for prosthetic structures for up to 6 months. They can be used in single- or two-stage procedures and they are intended to be placed out of occlusion. ### SUBJECT DEVICE DESCRIPTIONS The subject device is a temporary abutment composed of PEEK with a titanium alloy fixation screw. The subject device is compatible with Neodent zirconia implant bodies with Zilock connection platform (K201491). - Intended for single use; - Provided sterile via Ethylene Oxide; - The subject devices are manufactured of PEEK (high performance polymer – specific for dental use) and are provided along with a screw manufactured of titanium alloy according to ASTM F136 standard; - . ZiLock prosthetic interface with internal indexer; - . Cylindrical format with a passing hole to fixate the screw. {5}------------------------------------------------ ### TECHNOLOGICAL CHARACTERISTIC COMPARISON TABLES | | SUBJECT DEVICE | PRIMARY PREDICATE DEVICE | REFERENCE DEVICE | | |-------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | K202282<br>Neodent Implant System - Zirconia Implant<br>System<br>PEEK CR Abutments<br>JJGC Indústria e Comércio de Materiais<br>Dentários S.A. | K163194<br>Neodent Implant System - GM Line<br>Pro PEEK Abutments<br>JJGC Indústria e Comércio de Materiais Dentários<br>S.A. | K191191<br>Neodent Implant System<br>GM Temporary Abutment for Crown<br>JJGC Indústria e Comércio de Materiais Dentários<br>S.A. | Equivalence<br>Discussion | | Indications for<br>Use | Neodent<br>prosthetic<br>abutments<br>are<br>indicated to be used on Neodent implants to<br>provide support for prosthetic structures for<br>up to 6 months. They can be used in single-<br>or two-stage procedures and they are<br>intended to be placed out of occlusion. | The Pro PEEK Abutments are indicated to be<br>used on Neodent implants to provide<br>temporary support for prosthesis structure<br>for up to 6 months. They can be used in one<br>or two stage procedures and also immediate<br>load when there is good primary stability | The Neodent Implant System is intended to<br>be surgically placed in the bone of the upper<br>or lower jaw to provide support for<br>prosthetic devices, such as artificial teeth, to<br>restore chewing function. It may be used<br>with single-stage or two-stage procedures,<br>for single or multiple unit restorations, and<br>may be loaded immediately when good<br>primary stability is achieved and with<br>appropriate occlusal loading. The Neodent<br>Implant System - Temporary Abutments are<br>indicated to be used on Neodent implants to<br>provide temporary support for prosthesis<br>structure for up to 6 months. | Equivalent<br>Despite of the use of different words, the<br>indications for use for the primary predicate<br>devices and subject devices are the same.<br>•<br>Both are indicated for temporary<br>support for a maximum period of<br>time of 6 months;<br>•<br>Both can be used in one or two<br>stage procedures;<br>•<br>Both can be used for immediate<br>load. | | Intended Use | The PEEK CR Abutment for Zirconia is a<br>device indicated for use in the production of<br>a single-unit provisional prosthesis on<br>Zirconia Implants, installed in maxilla or<br>mandible. It is supplied along with a screw<br>for fixating the Abutment over the Implant. | The Temporary Abutment is used for<br>temporary rehabilitation (up to 180 days)<br>with screw-retained single-unit (anti-<br>rotational abutment) or multi-unit<br>(rotational abutment) prostheses. | The Temporary Abutment is used for<br>temporary rehabilitation (up to 180 days)<br>with screw-retained single-unit (anti-<br>rotational abutment) or multi-unit<br>(rotational abutment) prostheses. | Equivalent<br>Subject devices and predicate devices are<br>indicated for temporary use only. | | Implant- | Straight internal connection | GM Morse Taper | GM Morse Taper | Equivalent | | Abutment<br>interface | indexing features (ZiLock) | | | Subject devices and predicate devices<br>present<br>internal connection and are<br>equipped with a rotational lock and an inner<br>thread for fixation of the components. | | Design | Cylindrical format with a passing hole to<br>fixate the screw and anti-rotational<br>implant- | Cylindrical format with a passing hole to<br>fixate the screw and anti-rotational<br>implant- | Cylindrical format with grooves to facilitate<br>bonding of acrylic<br>material and | Equivalent | | | SUBJECT DEVICE | PRIMARY PREDICATE DEVICE | REFERENCE DEVICE | | | | K202282<br>Neodent Implant System - Zirconia Implant<br>System<br>PEEK CR Abutments<br>JJGC Indústria e Comércio de Materiais<br>Dentários S.A. | K163194<br>Neodent Implant System - GM Line<br>Pro PEEK Abutments<br>JJGC Indústria e Comércio de Materiais Dentários<br>S.A. | K191191<br>Neodent Implant System<br>GM Temporary Abutment for Crown<br>JJGC Indústria e Comércio de Materiais Dentários<br>S.A. | Equivalence<br>Discussion | | | to-abutment interface | to-abutment interface | circumferential channels to facilitate<br>customization of abutment height. Presents<br>anti-rotational<br>implant-to-abutment<br>interface | Subject devices and predicate devices<br>present the same design and similar anti-<br>rotational feature. | | Reusable | No | No | No | Identical<br>The subject devices and the predicate devices<br>are indicated for single use. | | Length (mm) | 1.5; 2.5 mm | 0.8; 1.5; 2.5; 3.5; 4.5; 5.5 mm | 0.8; 1.5; 2.5; 3.5 mm | Equivalent<br>Range of lengths for subject devices is<br>within the range of lengths for the primary<br>and reference predicate devices. | | Diameter (Ø)<br>(mm) | 4.0; 4.5 mm | 4.5; 6.0 mm | 3.5; 4.5 mm | Equivalent<br>Diameter of subject devices is within the<br>range of diameters for the primary and<br>reference predicate devices, so the subject<br>devices do not represent a worst case in<br>terms of performance. | | Material | Body and base (implant-to-abutment<br>interface): PEEK (high performance<br>polymer - specific for dental use)<br>Screw: Titanium Alloy (ASTM F136) | Body: PEEK (high performance polymer -<br>specific for dental use)<br>Base (implant-to-abutment interface):<br>Titanium Alloy (ASTM F136)<br>Screw: Titanium Alloy (ASTM F136) | Titanium Alloy (ASTM F136) | Equivalent<br>Both primary and reference predicate<br>devices are made of the same raw materials.<br>The main difference between the predicate<br>devices and subject devices is the<br>composition of the subject device body<br>which is only PEEK. | | Sterilization<br>Method | Provided sterile via Ethylene Oxide to an<br>SAL of 1x10-6 | Provided sterile via Ethylene Oxide to an SAL of<br>1×10-6 | Provided sterile via Ethylene Oxide to an SAL<br>of 1x10-6 | Identical<br>Subject devices and predicate devices are<br>provided sterile by the same sterilization<br>method. | #### Table 1. Technological Characteristic Comparison Table {6}------------------------------------------------ ### K202282 – Traditional 510(k) Neodent Implant System – Zirconia Implant System {7}------------------------------------------------ The subject devices have equivalent indications for use as the primary predicate devices. They also present an equivalent range of lengths as the primary and reference devices and equivalent range of diameter as the reference predicate devices, being contemplated within the range of lengths and diameter of the predicate devices. Subject and predicate devices have implant-to-abutment internal indexing. They present the same sterile barrier system and same sterilization method. The subject devices and primary predicate devices are manufactured of the same materials. Overall, the subject devices are equivalent to the predicate devices as follows: - same intended use, - . same operating principle, - incorporate the same basic design, - . incorporate the same materials, and - have same packaging and are sterilized using the same materials and processes ### PERFORMANCE DATA ### Biocompatibility Biocompatibility for the subject devices was leveraged from the primary predicate device K163194. Ethylene oxide sterilization residuals according to ISO 10993-7 was also leveraged from the primary predicate device K163194. #### Bench testing The subject devices are not intended to be placed in occlusion and are not intended to correct angled implants. Therefore, there would be no forces focusing on them, so the company understands that the Dynamic Fatigue Test is not applicable. MRI compatibility testing was leveraged from the reference device K182620. ### Sterilization validation The subject devices are sterilized by Ethylene Oxide, according to ISO 11135-1 via the over-kill method. The method achieved a Sterility Assurance Level of 1x10 °. The Subject devices are not represented to be "pyrogen free". Bacterial Endotoxin Testing is leveraged from the primary predicate device K163194. ### CONCLUSION The subject devices and the predicate devices have equivalent intended use, design and technological characteristics. Equivalent range of overall dimensions and sterilization method. The data included in this submission demonstrate that the subject devices are substantially equivalent to the predicate devices.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%